Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bally

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
The Plant Cell|February 15, 2022
Monolignol export by diffusion down a polymerization-induced concentration gradientMendel L Perkins, Mathias Schuetz, Faride Unda, et al.
Physical Review Letters|May 17, 2024
Ab Initio Uncertainty Quantification of Neutrinoless Double-Beta Decay in ^{76}GeA Belley, J M Yao, B Bally, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Phase I study of liposomal vincristineK A Gelmon, A Tolcher, A R Diab, et al.
Chemistry and Physics of Lipids|March 1, 1990
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a surveyT D Madden, P R Harrigan, L C Tai, et al.
Cancer Letters|January 24, 2026
Copper ionophores drive divergent responses to immune checkpoint inhibition across colorectal tumor modelsDevon Heroux, Xu Xin Sun, Sijie Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 25, 2006
In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserineMurray S Webb, Sharon Johnstone, Tara J Morris, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 16, 2014
Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancerRobert Neijzen, May Q Wong, Navdeep Gill, et al.
Oncotarget|July 30, 2015
3'-Phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agentsAda W Y Leung, Wieslawa H Dragowska, Daniel Ricaurte, et al.
Investigational New Drugs|July 28, 2014
Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicitiesDawn N Waterhouse, Brent W Sutherland, Nancy Dos Santos, et al.
Bioscience Reports|November 14, 2002
Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol)C Allen, N Dos Santos, R Gallagher, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
The Plant Cell|February 15, 2022
Monolignol export by diffusion down a polymerization-induced concentration gradientMendel L Perkins, Mathias Schuetz, Faride Unda, et al.
Physical Review Letters|May 17, 2024
Ab Initio Uncertainty Quantification of Neutrinoless Double-Beta Decay in ^{76}GeA Belley, J M Yao, B Bally, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Phase I study of liposomal vincristineK A Gelmon, A Tolcher, A R Diab, et al.
Chemistry and Physics of Lipids|March 1, 1990
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a surveyT D Madden, P R Harrigan, L C Tai, et al.
Cancer Letters|January 24, 2026
Copper ionophores drive divergent responses to immune checkpoint inhibition across colorectal tumor modelsDevon Heroux, Xu Xin Sun, Sijie Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 25, 2006
In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserineMurray S Webb, Sharon Johnstone, Tara J Morris, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 16, 2014
Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancerRobert Neijzen, May Q Wong, Navdeep Gill, et al.
Oncotarget|July 30, 2015
3'-Phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agentsAda W Y Leung, Wieslawa H Dragowska, Daniel Ricaurte, et al.
Investigational New Drugs|July 28, 2014
Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicitiesDawn N Waterhouse, Brent W Sutherland, Nancy Dos Santos, et al.
Bioscience Reports|November 14, 2002
Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol)C Allen, N Dos Santos, R Gallagher, et al.
Pageof 23